Brief: Pfizer Says Drug Pricing Agreement With US Government Has No Impact On 2025 Guidance
Brief: Novo Nordisk Submits Updated Proposal To Acquire Metsera
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up (updated)
Brief: Pfizer And Novo Nordisk Sweeten Offers For Metsera As Bidding War Intensifies - FT
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion
Pfizer’s obesity takeover requires a booster shot
Pfizer raises 2025 profit forecast for second time in a row (updated)
Pfizer raises 2025 profit forecast for second time in a row
Preview: Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight
U.S. STOCKS ON THE MOVE-Eli Lilly, Palantir, Tesla
Novo Nordisk says Metsera bid won't raise antitrust issues (updated)
Brief: Novo Nordisk Spokesperson Says Pfizer's Claims Against Co's Metsera Offer Is "Without Merit"
Novo Nordisk says Metsera bid won't raise antitrust issues
Brief: Metsera To Address Pfizer's Litigation In Court
Pfizer’s obesity takeover requires a booster shot
U.S. STOCKS ON THE MOVE-Amazon, Nvidia, MongoDB
Metsera falls after Pfizer files a second lawsuit against co and Novo
Pfizer files second lawsuit against Metsera, Novo Nordisk (updated)
Pfizer files second lawsuit against Metsera, Novo Nordisk